Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate |
2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67c731497cca00d1add4abb55122ced http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dcaebc2eb94ec91ba87d4a23f040446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3978bdcc399a5027bdb788b58d0fcdfa |
publicationDate |
2020-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-3117761-A1 |
titleOfInvention |
Joint use of compound a and compound b in preparation of medications for treatment of gout or hyperuricemia |
abstract |
The present disclosure relates to the joint use of compound A and compound B in the preparation of medications for the treatment of gout or hyperuricemia. Specifically, compound A is selected from the compound shown in Formula I, a pharmaceutical salt thereof, or an ester thereof, and compound B is selected from allopurinol or febuxostat. In particular, a method for treating gout or hyperuricemia in which the compound shown in Formula I-1 works in conjunction with febuxostat shows good treatment effect. |
priorityDate |
2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |